Design, synthesis, in silico pharmacokinetics prediction and biological evaluation of 1,4-dihydroindeno[1,2-c]pyrazole chalcone as EGFR /Akt pathway inhibitors.

Autor: Khan I; Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India., Garikapati KR; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India; Applied Biology Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India., Setti A; Department of Genetics, Osmania University, Hyderabad 500007, India., Shaik AB; Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India., Kanth Makani VK; Applied Biology Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India., Shareef MA; Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India., Rajpurohit H; Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India., Vangara N; Applied Biology Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India., Pal-Bhadra M; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India; Applied Biology Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India. Electronic address: manika@iict.res.in., Kamal A; School of Pharmaceutical Education and Research, Jamia Hamdard University, New Delhi 110062, India. Electronic address: ahmedkamal915@gmail.com., Kumar CG; Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address: cgkumar.iict@gov.in.
Jazyk: angličtina
Zdroj: European journal of medicinal chemistry [Eur J Med Chem] 2019 Feb 01; Vol. 163, pp. 636-648. Date of Electronic Publication: 2018 Dec 08.
DOI: 10.1016/j.ejmech.2018.12.011
Abstrakt: In an attempt to develop potent and selective anticancer agents, a series of 15 conjugates of 1,4-dihydroindeno[1,2-c]pyrazole chalcone (12a-o) were designed, synthesized and evaluated for their antiproliferative activity against MCF7, A549, MDA-MB-231, HCT116 and SKBR3 human cancer cell lines. Among them, 12h, 12l and 12m showed IC 50 values: 3.82, 5.33 and 4.21 μM, respectively, on A549 cell with respect to the positive control, Erlotinib (IC 50 value: 10.26 μM). Detailed biological assays showed accumulation of mitotic cells in G2/M phase. In addition, Western blot analysis and immunofluorescence study revealed inhibition of EGFR and Akt pathways. In silico computational studies were also carried out to predict the binding modes and pharmacokinetic parameters of these conjugates.
(Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: